Bristol University, Bristol, UK
Development of vaccines for the prevention of meningococcal B disease is a high public health priority and requires intensive research efforts, in particular to help elucidate the immunological...
University of Southampton, Southampton, UK
Clinical treatment of meningococcal disease involves antibiotic therapy, the administration of anti-inflammatory steroids (e.g. dexamethasone), and intensive care management.
Liverpool School of Tropical Medicine, Liverpool, UK, Health Bureau of Southern Ethiopia, Addis Ababa, Ethiopia
The project aims to further develop forecasting models to predict meningitis epidemics within sub-Saharan Africa by incorporating epidemiological, weather and environmental information at the local...
University of Illinois, Chicago, USA
With the exception of group B meningococci, successful polysaccharide (capsule)-protein conjugate vaccines are available to prevent the most common causes of bacterial meningitis in humans.
Imperial College School of Medicine at St Mary's Hospital, London, UK
Myocardial dysfunction is a major component in the pathophysiology of meningococcal septic shock, and is the principal cause of death.
University of Sussex, Brighton, UK
Streptococcus pneumoniae is a major cause of meningitis, particularly among children and the elderly.